Achievements
-
.USD 1= USD 3.5
of investment impact thanks to direct and in-kind support from partners
-
.Single-dosetafenoquine
for relapse prevention of P. vivax malaria approved by the US FDA
-
.>90%of severe malaria cases
now treated with injectable artesunate in preference to quinine across 6 countries through the MMV-led ISMO project
Defeating malaria together
Featured resources
-
Why we must prioritize malaria treatment for children
Jan 2019 -
Evaluation of the effects on the QT interval of 4 artemisinin-based combination therapies for the treatment of uncomplicated malaria by use of a correction-free and heart rate-free method
Jan 2019 -
Effects of Dihydroartemisinin-Piperaquine Phosphate and Artemether-Lumefantrine on QTc Interval Prolongation
Jan 2019
